HCC podcast series part 1: The use of IO in unresectable HCC

November 21, 2024 00:23:21
HCC podcast series part 1: The use of IO in unresectable HCC
COR2ED - Oncology Medical Conversation
HCC podcast series part 1: The use of IO in unresectable HCC

Nov 21 2024 | 00:23:21

/

Show Notes

In the first of this 4-part podcast series on HCC, Dr Rachna Shroff and Oncology Brothers Drs Rohit and Rahul Gosain explore the use of IO (immunotherapy) in unresectable HCC (uHCC) and take a deep dive into the different treatment options first-line focusing on IO and IO based combinations. Topics include: 

 

 

Key clinical takeaways:

 

 

Follow us on social media: 

LinkedIn: https://www.linkedin.com/company/hcc-connect  

X: https://x.com/hccconnectinfo  

 

This content is intended for healthcare professionals only.  

The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution. AstraZeneca has provided a sponsorship grant towards this independent programme. 

 

This podcast is developed by cor2ed.com 

Published on November 2024 

 

Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released. 

Other Episodes

Episode

December 06, 2023 00:27:27
Episode Cover

Gastric and GEJ cancers: Clinical case discussions. Part 1 - non-metastatic disease

This podcast series consists of two episodes where expert oncologists Dr Sam Klempner (Massachusetts General Hospital, USA) and Dr Lizzy Smyth (Oxford University Hospitals...

Listen

Episode

December 06, 2023 00:22:49
Episode Cover

Prostate cancer: PARP inhibitors. Part 3 - Efficacy and safety of combination therapy

Dr Tanya Dorff, a Medical Oncologist from the City of Hope Comprehensive Cancer Center and Dr Neeraj Agarwal, Medical Oncologist and Director of the...

Listen

Episode

December 06, 2023 00:21:52
Episode Cover

Thyroid cancer: Optimising VEGFR-TKIs (MKIs) in differentiated thyroid cancer

Dr. Jaume Capdevila, a Medical Oncologist at Vall d’Hebron University Hospital in Barcelona, Spain, and Dr. Rachel van Leeuwaarde, an Endocrinologist from the University...

Listen